Showing 201 - 220 results of 380 for search '"Schizophrenia"', query time: 0.07s Refine Results
  1. 201
  2. 202
  3. 203
  4. 204

    A cognitive model of perceptual anomalies: The role of source monitoring, top-down influence and inhibitory processes for hallucinations in schizophrenia spectrum disorders and hallucinatory-like experiences in the general population by Adrianna Aleksandrowicz, Joachim Kowalski, Steffen Moritz, Izabela Stefaniak, Łukasz Gawęda

    Published 2025-04-01
    “…Methods: Eighty-nine patients with schizophrenia spectrum disorders (SSD) were divided into two groups based on AHs presence - 46 with AHs and 43 - non-hallucinating, 43 matched healthy controls (HC), and a sample selected from the general population of 40 participants with high HLEs and 43 with low HLEs performed three experimental tasks assessing top-down processes (False Perception Task - FPT), source monitoring (Action Memory Task - AMT), and inhibitory control (Go/No-Go Task). …”
    Get full text
    Article
  5. 205
  6. 206

    Patients’ acceptability and implementation outcomes of a case management approach to encourage participation in colorectal cancer screening for people with schizophrenia: a qualitative secondary analysis of a mixed-method randomised clinical trial by Tempei Miyaji, Yosuke Uchitomi, Hiroyuki Okada, Masatoshi Inagaki, Maiko Fujimori, Taichi Shimazu, Masaki Fujiwara, Masafumi Kodama, Ryuhei So, Takanori Matsushita, Yusaku Yoshimura, Shigeo Horii, Hirokazu Takahashi, Naoki Nakaya, Shiro Hinotsu, Keita Harada, Norihito Yamada, Yuto Yamada, Tsuyoshi Etoh

    Published 2022-06-01
    “…Objectives We examined the efficacy of case management (CM) interventions to encourage participation in colorectal cancer screening for patients with schizophrenia. This study aimed to clarify patients’ acceptability of the intervention and the helpful components of the intervention. …”
    Get full text
    Article
  7. 207
  8. 208
  9. 209
  10. 210
  11. 211
  12. 212
  13. 213
  14. 214
  15. 215
  16. 216
  17. 217

    Phenothiazines and their Evolving Roles in Clinical Practice: A Narrative Review by Amber N. Edinoff, Grace Armistead, Christina A Rosa, Alexandra Anderson, Ronan Patil, Elyse M Cornett, Kevin S. Murnane, Adam M. Kaye, Alan D. Kaye

    Published 2022-11-01
    “…Phenothiazines have been used for decades to treat mental illnesses, including schizophrenia, mania in bipolar disorder, and psychosis. …”
    Get full text
    Article
  18. 218

    Cotard Syndrome without Depressive Symptoms in a Schizophrenic Patient by Pedro Morgado, Ricardo Ribeiro, João J. Cerqueira

    Published 2015-01-01
    “…We present a case of Cotard syndrome without depressive symptoms in the context of known paranoid schizophrenia. A literature review of Cotard syndrome in schizophrenia was performed. …”
    Get full text
    Article
  19. 219
  20. 220

    Effects of Chronic Dopamine D2R Agonist Treatment and Polysialic Acid Depletion on Dendritic Spine Density and Excitatory Neurotransmission in the mPFC of Adult Rats by Esther Castillo-Gómez, Emilio Varea, José Miguel Blasco-Ibáñez, Carlos Crespo, Juan Nacher

    Published 2016-01-01
    “…Dopamine D2 receptors (D2R) in the medial prefrontal cortex (mPFC) are key players in the etiology and therapeutics of schizophrenia. The overactivation of these receptors contributes to mPFC dysfunction. …”
    Get full text
    Article